Although there is currently no specific inhibitor of PLA2G2A for the clinical treatment of cancer, tanshinone I has been reported to inhibit PLA2G2A and could disrupt cellular PUFA metabolism for the synthesis of eicosanoids [23]. This evidence concerns the gene PLA2G2A and cancer.